FUND PARTICIPATION AGREEMENT
THIS AGREEMENT is entered into as of this 1st day November, 2005, among
FIRST METLIFE INVESTORS INSURANCE COMPANY (the "Company") a life insurance
company organized under the laws of the State of New York (on behalf of itself
and certain of its separate accounts); AMERICAN FUNDS INSURANCE SERIES
("Series"), an open-end management investment company organized under the laws
of the Commonwealth of Massachusetts, and CAPITAL RESEARCH AND MANAGEMENT
COMPANY ("CRMC"), a corporation organized under the laws of the State of
Delaware.
WITNESSETH:
WHEREAS, the Company proposes to issue, now and in the future, certain
multi-manager variable contracts that provide certain funds (the "Funds" and
each, a "Fund") of the Series as investment options (the "Contracts");
WHEREAS, the Company has established pursuant to New York insurance law one
or more separate accounts (each, an "Account") for purposes of issuing the
Contracts, which Accounts and Contracts are listed on Exhibit A;
---------
WHEREAS, the Company has registered or will register certain variable life
insurance contracts under the 1933 Act or will not register the contracts in
proper reliance on an exemption from registration under the 1933 Act; and
WHEREAS, the Company has registered or will register each Account as a unit
investment trust under the 1940 Act or alternatively, has properly relied on an
exclusion of the 1940 Act; and
WHEREAS, the Contracts, which are or will be registered (unless exempt from
such registration) by the Company with the Commission for offer and sale, will
be in material compliance with all applicable laws prior to being offered for
sale;
WHEREAS, the Series has received a "Mixed and Shared Funding Order" from
the Commission granting relief from certain provisions of the 1940 Act and the
rules thereunder to the extent necessary to permit shares of the Series to be
sold to variable annuity and life insurance separate accounts of unaffiliated
insurance companies;
WHEREAS, the Series is divided into various Funds, each Fund being subject
to certain fundamental investment policies which may not be changed without a
majority vote of the shareholders of such Fund;
WHEREAS, certain Funds listed in Exhibit B to this Agreement will serve as
---------
certain of the underlying investment mediums for the Contracts; and
WHEREAS, CRMC is the investment adviser for the Series.
NOW, THEREFORE, in consideration of the foregoing and of mutual covenants
and conditions set forth herein and for other good and valuable consideration,
the Company, the Series and CRMC hereby agree as follows:
1. The Series and CRMC each represents and warrants to the Company that:
(a) a registration statement under the 1933 Act and under the 1940 Act with
respect to the Series has been filed with the Commission in the form previously
delivered to the Company, and copies of any and all amendments thereto will be
forwarded to the Company at the time that they are filed with the Commission;
(b) the Series is, and shall be at all times while this Agreement is in force,
lawfully organized, validly existing, and properly qualified as an open-end
management investment company in accordance with the laws of the Commonwealth of
Massachusetts; and (c) the Series' registration statement and any further
amendments thereto will, when they become effective, and all definitive
prospectuses and statements of additional information and any further
supplements thereto (the "Prospectus") shall, conform in all material respects
to the requirements of the 1933 Act and the 1940 Act and the rules and
regulations of the Commission thereunder, and will not contain any untrue
statement of a material fact or omit to state a material fact required to be
stated therein or necessary to make the statement therein not misleading;
provided, however, that this representation and warranty shall not apply to any
statements or omissions made in reliance upon and in conformity with information
furnished in writing to the Series by the Company expressly for use therein.
2. The Series will furnish to the Company such information with respect to
the Series in such form and signed by such of its officers as the Company may
reasonably request, and will warrant that the statements therein contained when
so signed will be true and correct. The Series will advise the Company
immediately of: (a) the issuance by the Commission of any stop order suspending
the effectiveness of the registration statement of the Series or the initiation
of any proceeding for that purpose; (b) the institution of any proceeding,
investigation or hearing involving the offer or sale of the Contracts or the
Series of which it becomes aware; or (c) the happening of any material event, if
known, which makes untrue any statement made in the registration statement of
the Series or which requires the making of a change therein in order to make any
statement made therein not misleading.
3. The Series will use best efforts to register for sale under the 1933 Act
and, if required, under state securities laws, such additional shares of the
Series as may reasonably be necessary for use as the funding vehicle for the
Contracts.
4. The Series agrees to make Class 2 shares of the Funds listed on Exhibit
B hereto available to the Contracts. The Company will be entitled to a Rule
12b-l service fee paid by the Series and to be accrued daily and paid monthly at
an annual rate of 0.25% of the average daily net assets of the Class 2 shares of
each Fund attributable to the Contracts for personal services and account
maintenance services for Contract owners with investments in subaccounts
corresponding to the Class 2 shares of each Fund (each, a "Subaccount") for as
long as the Series' Plan of Distribution pursuant to Rule 12b-l under the 1940
Act (the "12b-l plan")
2
remains in effect. Fund shares to be made available to Accounts for the
Contracts shall be sold by the Series and purchased by the Company for a given
Account at the net asset value of the respective class of the respective Fund
(without the imposition of a sales load) next computed after receipt of each
order by the Series or its designee, as established in accordance with the
provisions of the then current Prospectus of the Series. For purposes of this
Paragraph 4, the Company shall be a designee of the Series for receipt of such
orders from each Account, and receipt by such designee by 4:00 p.m. Eastern time
(or other such time the Board of Trustees of the Series shall so designate)
shall constitute receipt by the Series; provided that the Series receives notice
of such order by 8:30 a.m. Eastern time on the following Business Day ("Next
Business Day"). "Business Day" shall mean any day on which the New York Stock
Exchange ("NYSE") is open for trading and on which the Series calculates the net
asset values of each class of shares of each Fund pursuant to the rules of the
Commission. The Series will make the shares of each class of each Fund available
indefinitely for purchase at the applicable net asset value per share by the
Company and its Accounts on those days on which the Series calculates the net
asset values of each such class pursuant to the rules of the Commission, and the
Series shall use its best efforts to calculate such net asset values on each day
on which the NYSE is open for trading. The Series shall make the net asset value
per share for each class of each Fund available to the Company on a daily basis
as soon as reasonably practical after the Series calculates such net asset
values per share, and the Series shall use its best efforts to make such net
asset values per share available by 6:30 p.m. Eastern time. CRMC and the Series
shall report to the Company any material error in the calculation of the net
asset values, dividends or capital gain information as soon as practicable upon
discovery. The Series and CRMC are responsible for maintaining net asset values
for each class of each Fund in accordance with the requirements of the 1940 Act
and the Series' then current Prospectus. Payments for shares purchased will be
made in federal funds transmitted by wire on the Next Business Day, and the
Company and the Fund shall each use commercially reasonable efforts to wire (or
cause to be wired) funds to the other, for the purpose of settling net purchase
orders or orders of redemption, by 3:00 p.m. Eastern time on the Next Business
Day.
The Series reserves the right to temporarily suspend sales if the Board of
Trustees of the Series deems it appropriate and in the best interests of the
Series or in response to the order of an appropriate regulatory authority. The
Company reserves the right to refuse, to impose limitations on, or to limit any
transaction request if the request would tend to disrupt Contract administration
or is not in the best interest of the Contract holders or an Account or
Subaccount.
5. The Contracts funded through each Account will provide for the
allocation of net amounts among certain Subaccounts for investment in shares of
a class of the Funds as may be offered from time to time in the Contracts. The
selection of the particular Subaccount is to be made by the Contract owner and
such selection may be changed in accordance with the terms of the Contracts.
6. Transfer of the Series' shares will be by book entry only. No stock
certificates will be issued to the Account. Shares ordered from a particular
Fund will be recorded by the Series as instructed by the Company in an
appropriate title for the corresponding Account or Subaccount.
3
7. The Series shall furnish notice promptly to the Company of any dividend
or distribution payable on any shares underlying Subaccounts. The Company hereby
elects to receive all such dividends and distributions as are payable on shares
of a Fund recorded in the title for the corresponding Subaccount in additional
shares of that Fund. The Series shall notify the Company of the number of shares
so issued. The Company reserves the right to revoke this election and to receive
all such income dividends and capital gain distributions in cash.
8. The Series shall redeem for cash its shares in accordance with the terms
of its then current Prospectus. For purposes of this Paragraph 8, the Company
shall be a designee of the Series for receipt of requests for redemption from
each Account, and receipt by such designee by 4:00 p.m. Eastern time (or other
such time the Board of Trustees of the Series shall so designate) shall
constitute receipt by the Series; provided that the Series receives notice of
such request for redemption by 8:30 a.m. Eastern time on the Next Business Day.
The Company shall purchase and redeem the shares of Funds offered by the then
current Prospectus of the Series in accordance with the provisions of such
Prospectus.
9. The Series shall pay all expenses incidental to its performance under
this Agreement. The Series shall see to it that all of its shares are registered
and authorized for issue in accordance with applicable federal and state laws
prior to their purchase for the Account. The Series shall bear the expenses for
the cost of registration of its shares, preparation of prospectuses and
statements of additional information to be sent to existing Contract owners
(upon request in the case of the statement of additional information), proxy
statements and related materials and annual and semi-annual shareholder reports,
the printing and distribution of such items to each Contract owner who has
allocated net amounts to any Subaccount, the preparation of all statements and
notices required from it by any federal or state law, and taxes on the issue or
transfer of the Series' shares subject to this Agreement. The Series will
provide the Company, at least once a year, with enough copies of its Statement
of Additional Information to be able to distribute one to each Contract owner or
prospective Contract owner who requests such Statement of Additional
Information.
10. The Company shall bear the expenses for the cost of preparation and
delivery of Series prospectuses (and supplements thereto) to be sent to
prospective Contract owners. The Series shall provide, at its expense, such
documentation (in camera-ready or other mutually agreeable form) and other
assistance as is reasonably necessary in order for the Company once each year
(or more frequently if the prospectus for the Series is amended), and twice each
year in the case of the annual and semi-annual shareholder reports, to have the
prospectus or prospectuses, and the annual and semi-annual shareholder reports
for the Contracts and the Series, printed together in one or more documents
(such printing to be done at the Company's expense with respect to prospective
investors).
11. The Company represents and warrants to the Series that any information
furnished in writing by the Company to the Series for use in the registration
statement of the Series will not result in the registration statement's failing
to conform in all respects to the requirements of the 1933 Act and the 1940 Act
and the rules and regulations thereunder or containing any untrue statement of a
material fact or omission to state a material fact required to be stated therein
or
4
necessary to make the statements therein not misleading.
12. CRMC and AFD represent and warrant to the Company and MetLife Investors
Distribution Company (the "Distributor") that any information furnished in
writing by CRMC or AFD to the Company for use in the registration statements for
the Contracts will not result in the registration statement's failing to conform
in all respects to the requirements of the 1933 Act and the 1940 Act and the
rules and regulations thereunder or containing any untrue statement of a
material fact or omission to state a material fact required to be stated therein
or necessary to make the statements therein not misleading.
13. The Company and its affiliates shall make no representations concerning
the Series' shares except those contained in the then current Prospectus of the
Series, in such printed information subsequently issued on behalf of the Series
or other funds managed by CRMC as supplemental to the Series' Prospectus, in
information published on the Series' or CRMC's internet site, or in materials
approved by AFD, as provided in the Business Agreement in effect among the
Company, the Distributor, AFD and CRMC dated as of , 2005 (the
--------------
"Business Agreement").
14. CRMC and its affiliates shall make no representations concerning the
Contracts except those contained in the then current Prospectus of the
Contracts, in such printed information subsequently issued on behalf of the
Contracts, in information published on the Company's internet site, or in
materials approved by the Company or the Distributor, as provided in the
Business Agreement.
15. Shares of the Series may be offered to separate accounts of various
insurance companies in addition to the Company. The Series represents, warrants
and covenants that no shares of the Series shall be sold to the general public
in contravention of Section 817 of the Internal Revenue Code of 1986, as
amended, and the regulations thereunder (the "Code"). The Series represents,
warrants and covenants that each Fund will comply with the diversification
requirements of Section 817. The Series also represents, warrants and covenants
to maintain each Fund's qualification as a "regulated investment company"
("RIC") under the Code. The Series will provide the Company with securities
holdings reports for each Fund within ten days after each calendar quarter.
16. The parties to this Agreement recognize that due to differences in tax
treatment or other considerations, the interests of various Contract owners
participating in one or more Funds might, at some time, be in conflict. Each
party shall report to the other party any potential or existing conflict of
which it becomes aware. The Board of Trustees of the Series shall promptly
notify the Company of the existence of irreconcilable material conflict and its
implications. If such a conflict exists, the Company will, at its own expense,
take whatever action it deems necessary to remedy such conflict; in any case,
Contract owners will not be required to bear such expenses.
5
The Series hereby notifies the Company that it may be appropriate to
include in the Prospectus pursuant to which a Contract is offered disclosure
regarding the risks of mixed and shared funding.
17. The Company agrees to indemnify and hold the Series harmless against,
any and all losses, claims, damages, liabilities or litigation (including legal
and other expenses) to which the Series may be subject under any statute, at
common law or otherwise, insofar as such losses, claims, damages, liabilities or
expenses (or actions in respect thereof) or settlements arising as a result of
the Company's: (a) making untrue statements of material facts or omitting
material facts in a Contract's registration statement, prospectus, statement of
additional information, semi-annual or annual reports to Contract owners and
sales literature for the Contracts; (b) making untrue statements of material
facts that the Series includes in the same materials of the Series, provided
that Series relies on information supplied by the Company; (c) unlawful conduct,
bad faith, willful malfeasance, or gross negligence by the Company with respect
to the sale of the Contracts or Fund shares; and (d) materially breaching this
Agreement or a representation or warranty.
18. The Series and CRMC each agrees to indemnify and hold the Company
harmless against any and all losses, claims, damages, liabilities or litigation
(including legal and other expenses) to which the Company may be subject under
any statute, at common law or otherwise, insofar as such losses, claims,
damages, liabilities or expenses (or actions in respect thereof) or settlements
arising as a result of the Series', or CRMC's: (a) making untrue statements of
material facts or omitting material facts in the Series' registration statement,
prospectuses or statements of additional information, semi-annual and annual
reports to shareholders, and sales literature; (b) making untrue statements of
material facts that the Series includes in its materials, provided the Company
relies on information supplied by the Series; (c) unlawful conduct, bad faith,
willful malfeasance, or gross negligence by the Series with respect to the sale
of the Contracts or Fund shares or the operation of the Series or a Fund; (d)
failure of the Series to comply with any Fund's investment objectives, policies
and restrictions_described in the Prospectus; and (e) materially breaching this
Agreement or a representation or warranty, including, but not limited to, the
representations, warranties and covenants in Section 13.
19. The Company shall be responsible for assuring that the Account
calculates pass- through voting privileges of Contract owners in a manner
consistent with the method of calculating pass-through voting privileges set
forth in the current Contract.
20. The Series and CRMC will comply in all material respects with all
provisions of the 1940 Act requiring voting by shareholders.
21. The parties understand that there is no intention to create a joint
venture in the subject matter of this Agreement. Accordingly, the right to
terminate this Agreement and to engage in any activity not inconsistent with
this Agreement is absolute. This Agreement will terminate:
(a) by mutual agreement at any time; or
6
(b) any party at any time upon sixty days' written notice to the other
parties; or
(c) at the option of the Company, CRMC or the Series upon ten calendar
days' prior written notice to the other party if a final
non-appealable administrative or judicial decision is entered against
the other party which has a material impact on the Contracts;
(d) at the option of the Company, upon ten calendar days' prior written
notice, if shares of the Series are not reasonably available;
(e) at the option of the Company, immediately upon written notice, if the
Series or CRMC fails to meet the requirements for either
diversification under Section 817 or RIC status under the Code, or if
the Board of the Series terminates the 12b-l plan; or
(f) in the event the Series' shares are not registered, issued or sold in
accordance with applicable state and/or federal law or such law
precludes the use of such shares as an underlying investment for the
Contracts issued or to be issued by the Company; in such event prompt
notice shall be given by the Company or the Series to the other party.
(g) at the Company's option by written notice to AFD and/or CRMC if the
Company shall determine in its sole judgment exercised in good faith,
that either AFD or CRMC has suffered a material adverse change in its
business, operations, financial condition or prospects since the date
of this Agreement or is the subject of material adverse publicity.
(h) at the option of AFD or CRMC by written notice to the Company if AFD
or CRMC shall determine in its sole judgment exercised in good faith,
that the Company has suffered a material adverse change in its
business, operations, financial condition or prospects since the date
of this Agreement or is the subject of material adverse publicity.
The effective date for termination pursuant to any notice given under this
Paragraph shall be calculated beginning with the date of receipt of such notice.
22. All notices, consents, waivers, and other communications under this
Agreement must be in writing, and will be deemed to have been duly received: (a)
when delivered by hand (with written confirmation of receipt); (b) when sent by
telecopier (with written confirmation of receipt), provided that a copy is
mailed by registered mail, return receipt requested; or (c) the day after it is
sent by a nationally recognized overnight delivery service, in each case to the
appropriate addresses and telecopier numbers set forth below (or to such other
addresses and facsimile numbers as a party may designate by notice to the other
parties):
7
IF TO THE COMPANY:
First MetLife Investors Insurance Company
▇ ▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇
▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇
Attention: President
WITH A COPY TO:
First MetLife Investors Insurance Company
▇ ▇▇▇▇ ▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇
▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇
Attention: General Counsel
IF TO SERIES:
American Funds Insurance Series
▇▇▇ ▇. ▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇ ▇▇▇▇▇
▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇
Attention: ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇, Senior Vice President
Facsimile No.: (▇▇▇) ▇▇▇-▇▇▇▇
WITH A COPY TO:
Capital Research and Management Company
▇▇▇ ▇. ▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇ ▇▇▇▇▇
▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇
Attention: ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇▇, Senior Vice President and Senior Counsel,
Fund Business Management Group
Facsimile No.: (▇▇▇)▇▇▇-▇▇▇▇
IF TO CRMC:
Capital Research and Management Company
▇▇▇ ▇. ▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇ ▇▇▇▇▇
▇▇▇ ▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇
Attention: ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇, Senior Vice President and Legal Counsel,
Fund Business Management Group, and Secretary
Facsimile No.: (▇▇▇)▇▇▇-▇▇▇▇
WITH A COPY TO:
Capital Research and Management Company
▇▇▇ ▇. ▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇ ▇▇▇▇▇
▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇
Attention: ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇▇, Senior Vice President and Senior Counsel,
Fund Business Management
Group Facsimile No.: (▇▇▇)▇▇▇-▇▇▇▇
23. If this Agreement terminates, any provision of this Agreement necessary
to the orderly windup of business under it will remain in effect as to that
business, after termination.
8
24. If this Agreement terminates, the Series, at the Company's option, will
continue to make additional shares of the Series available for all existing
Contracts as of the effective date of termination (under the same terms and
conditions as were in effect prior to termination of this Agreement with respect
to existing Contract owners), unless the Series liquidates or applicable laws
prohibit further sales. The Company agrees not to redeem shares unless: (i) the
Agreement is terminated pursuant to Section 18(e) or 18(f); (ii) legitimately
required to do so according to a Contract owner's request; or (iii) under an
order from the Commission or pursuant to a vote of Contract owners.
25. The obligations of the Series under this Agreement are not binding upon
any of the Trustees, officers, employees or shareholders (except CRMC if it is a
shareholder) of the Series individually, but bind only the Series' assets. When
seeking satisfaction for any liability of the Series in respect of this
Agreement, the Company and the Account agree not to seek recourse against said
Trustees, officers, employees or shareholders, or any of them, or any of their
personal assets for such satisfaction. Notwithstanding the foregoing, if the
Company seeks satisfaction for any liability of the Series in respect of this
Agreement, the Company (on behalf of itself or any Account) may seek recourse
against CRMC.
26. This Agreement shall be construed in accordance with the laws of the
Commonwealth of Massachusetts.
27. This Agreement and the parties' rights, duties and obligations under
this Agreement are not transferable or assignable by any of them without the
express, prior written consent of the other parties hereto. Any attempt by a
party to transfer or assign this Agreement or any of its rights, duties or
obligations under this Agreement without such consent is void; provided,
however, that a merger of, reinsurance arrangement by, or change of control of a
party shall not be deemed to be an assignment for purposes of this Agreement.
28. The following Paragraphs shall survive any termination of this
Agreement: 2, 4, 7, 17, 18,22-28.
29. Each party hereto shall cooperate with each other party and all
appropriate governmental authorities (including without limitation the SEC, the
NASD and state insurance regulators) and shall permit such authorities
reasonable access to its books and records in connection with any investigation
or inquiry relating to this Agreement or the transactions contemplated hereby.
Notwithstanding the generality of the foregoing, each party hereto further
agrees to furnish the state Insurance Commissioner with any information or
reports in connection with services provided under this Agreement which such
Commissioner may request in order to ascertain whether the insurance operations
of the Company are being conducted in a manner consistent with the state
insurance regulations and any other applicable law or regulations.
30. This Agreement (along with the Business Agreement) constitutes the
entire agreement among the parties pertaining to the Contracts, and supersedes
any and all prior agreements, understandings, documents, projections, financial
data, statements, representations
9
and warranties, oral or written, express or implied, between the parties hereto
and their respective affiliates, representatives and agents in respect of the
subject matter hereof. If there should be any conflict between the terms of this
Agreement and those of the Business Agreement, the terms of the Fund
Participation Agreement shall govern.
31. No waiver of any provision nor consent to any exceptions to the terms
of this Agreement shall be effective unless that waiver or consent is executed
in writing by the parties and then only for the specific purpose, extent and
instance so provided.
32. The provisions of this Agreement are severable. Should any provision
hereof be held unlawful or invalid by any competent authority, the remainder of
the Agreement shall remain in full force and effect.
IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be
duly executed and attested as of the date first above written.
FIRST METLIFE INVESTORS INSURANCE
COMPANY (ON BEHALF OF ITSELF AND EACH
ACCOUNT)
Attest:
/s/ illegible By: /s/ illegible
------------------------------------- ------------------------------------
Its: Executive Vice President
AMERICAN FUNDS INSURANCE SERIES
Attest:
By: /s/ illegible
------------------------------------- ------------------------------------
Its: Secretary
CAPITAL RESEARCH AND MANAGEMENT COMPANY
Attest:
By: /s/ illegible
------------------------------------- ------------------------------------
Its: Vice President and Secretary
Approved for Signature [GRAPHIC]
by CRMC Legal Dept.
10
Exhibit A
---------
----------------------------------------------------------------
First MetLife Investors Variable Annuity Account One Form 6010
----------------------------------------------------------------
Exhibit B
---------
Global Small Capitalization Fund (Class 2)
Growth Fund (Class 2)
Growth-Income Fund (Class 2)
Global Growth Fund (Class 2)
12